Article

Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene.

Washington University, St. Louis, Missouri 63110, USA.
Clinical Cancer Research (Impact Factor: 8.19). 05/2009; 15(8):2666-74. DOI: 10.1158/1078-0432.CCR-08-2335
Source: PubMed

ABSTRACT We have previously mapped a major susceptibility locus influencing familial lung cancer risk to chromosome 6q23-25. However, the causal gene at this locus remains undetermined. In this study, we further refined this locus to identify a single candidate gene, by fine mapping using microsatellite markers and association studies using high-density single nucleotide polymorphisms (SNP).
Six multigenerational families with five or more affected members were chosen for fine-mapping the 6q linkage region using microsatellite markers. For association mapping, we genotyped 24 6q-linked cases and 72 unrelated noncancer controls from the Genetic Epidemiology of Lung Cancer Consortium resources using the Affymetrix 500K chipset. Significant associations were validated in two independent familial lung cancer populations: 226 familial lung cases and 313 controls from the Genetic Epidemiology of Lung Cancer Consortium, and 154 familial cases and 325 controls from Mayo Clinic. Each familial case was chosen from one high-risk lung cancer family that has three or more affected members.
A region-wide scan across 6q23-25 found significant association between lung cancer susceptibility and three single nucleotide polymorphisms in the first intron of the RGS17 gene. This association was further confirmed in two independent familial lung cancer populations. By quantitative real-time PCR analysis of matched tumor and normal human tissues, we found that RGS17 transcript accumulation is highly and consistently increased in sporadic lung cancers. Human lung tumor cell proliferation and tumorigenesis in nude mice are inhibited upon knockdown of RGS17 levels.
RGS17 is a major candidate for the familial lung cancer susceptibility locus on chromosome 6q23-25.

0 Followers
 · 
317 Views
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study investigated causal attributions and attitudes toward a hypothetical lung cancer patient. Participants included 147 undergraduate students who read 1 of 3 vignettes about a man recently diagnosed with lung cancer. The vignettes were identical except for the causal description of the patient's lung cancer (genetic, smoking, or combined). Compared with the other 2 conditions, participants in the genetic condition believed the hypothetical patient had less control and less responsibility for his illness; they also noted more pity and less anger. There were no significant differences in these variables between the smoking and combined conditions. Information about genetic information appears to trigger more positive perceptions of lung cancer patients, but only in the absence of smoking histories.
    Journal of Applied Social Psychology 06/2013; 43(S1). DOI:10.1111/jasp.12053 · 0.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In an effort to identify novel biallelically inactivated tumor suppressor genes (TSGs) in sporadic invasive and preinvasive non-small-cell lung cancer (NSCLC) genomes, we applied a comprehensive integrated multiple 'omics' approach to investigate patient-matched, paired NSCLC tumor and non-malignant parenchymal tissues. By surveying lung tumor genomes for genes concomitantly inactivated within individual tumors by multiple mechanisms, and by the frequency of disruption in tumors across multiple cohorts, we have identified a putative lung cancer TSG, Eyes Absent 4 (EYA4). EYA4 is frequently and concomitantly deleted, hypermethylated and underexpressed in multiple independent lung tumor data sets, in both major NSCLC subtypes and in the earliest stages of lung cancer. We found that decreased EYA4 expression is not only associated with poor survival in sporadic lung cancers but also that EYA4 single-nucleotide polymorphisms are associated with increased familial cancer risk, consistent with EYA4s proximity to the previously reported lung cancer susceptibility locus on 6q. Functionally, we found that EYA4 displays TSG-like properties with a role in modulating apoptosis and DNA repair. Cross-examination of EYA4 expression across multiple tumor types suggests a cell-type-specific tumorigenic role for EYA4, consistent with a tumor suppressor function in cancers of epithelial origin. This work shows a clear role for EYA4 as a putative TSG in NSCLC.Oncogene advance online publication, 7 October 2013; doi:10.1038/onc.2013.396.
    Oncogene 10/2013; DOI:10.1038/onc.2013.396 · 8.56 Impact Factor

Full-text (2 Sources)

Download
53 Downloads
Available from
May 22, 2014